Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy[2] Bezafibrate,
Ursodeoxycholic acid (Synonym: UDCA)		[2] D00734 ,
D01366 		[2] NR1H4,
PPARA 💬		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 94
2UDCA[1] Ursodeoxycholic acid (Synonym: UDCA)[1] D00734 [1] NR1H4 💬[1] Bile secretion 💬[6] 46, 67, 93, 94, 97, 296
3UDCA (Ursodeoxycholic acid)[1] Ursodeoxycholic acid (Synonym: UDCA)[1] D00734 [1] NR1H4 💬[1] Bile secretion 💬[1] 93
4Ursodeoxycholic acid (UDCA)[1] Ursodeoxycholic acid (Synonym: UDCA)[1] D00734 [1] NR1H4 💬[1] Bile secretion 💬[1] 94
5Ursodeoxycholic acid (UDCA) 500 mg[1] Ursodeoxycholic acid (Synonym: UDCA)[1] D00734 [1] NR1H4 💬[1] Bile secretion 💬[1] 46
6Ursodiol (ursodeoxycholic acid, UDCA)[1] Ursodeoxycholic acid (Synonym: UDCA)[1] D00734 [1] NR1H4 💬[1] Bile secretion 💬[1] 97